Filing Flows › VitaNova Life Sciences (VNOV) › Gross margin
VitaNova Life Sciences (VNOV) gross margin by quarter
VitaNova Life Sciences' gross margin was 61.1% in Q2 FY26 (second quarter fiscal 2026), +1.8 pts from Q4 FY25. Over the last 3 quarters it ranged from 59.3% (Q4 FY25) to 61.4% (Q3 FY25).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY26 | 61.1% | +1.8 pts | — |
| Q4 FY25 | 59.3% | -2.1 pts | — |
| Q3 FY25 | 61.4% | — | — |
Q2 FY26 at a glance
VitaNova Life Sciences, Q2 FY26: revenue $427K (+46% year over year), operating margin 23.2%, net earnings $36K, operating cash flow $213K. The chart follows the revenue to costs, profit and cash.
Questions
What is VitaNova Life Sciences' gross margin?
VitaNova Life Sciences' gross margin was 61.1% in Q2 FY26 (second quarter fiscal 2026), +1.8 pts from Q4 FY25.
How has VitaNova Life Sciences' gross margin changed?
Over the last 3 quarters it ranged from 59.3% (Q4 FY25) to 61.4% (Q3 FY25).
Q2 FY26 results → · How VitaNova Life Sciences makes money →